Modulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by Ca2+ antagonists

Mol Cell Biochem. 1988 Nov;84(1):65-76. doi: 10.1007/BF00235194.

Abstract

The purpose of this study was to examine the effect of three classes of Ca2+ antagonists, diltiazem, verapamil and nifedipine on Na+-Ca2+ exchange mechanism in the sarcolemmal vesicles isolated from canine heart. Na+-Ca2+ exchange and Ca2+ pump (ATP-dependent Ca2+ uptake) activities were assessed using the Millipore filtration technique. Sarcolemmal vesicles used in this study are estimated to consist of several subpopulations wherein 23% are inside-out and 55% are right side-out sealed vesicles in orientation. The affect of each Ca2+ antagonist on the Na+ dependent Ca2+ uptake was studied in the total population of sarcolemmal vesicles, in which none of the agents depressed the initial rate of Ca2+ uptake until concentrations of 10 microM were incubated in the incubation medium. However, when sarcolemmal vesicles were preloaded with Ca2+ via ATP-dependent Ca2+ uptake, cellular Ca2+ influx was depressed only by verapamil (28%) at 1 microM in the efflux medium with 8 mM Na+. Furthermore, inhibition of Ca2+ efflux by verapamil was more pronounced in the presence of 16 mM Na+ in the efflux medium. The order of inhibition was verapamil greater than diltiazem greater than nifedipine. These results indicate that same forms of Ca2+-antagonist drugs may affect the Na+-Ca2+ exchange mechanism in the cardiac sarcolemmal vesicles and therefore we suggest this site of action may contribute to their effects on the myocardium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / physiology
  • Alamethicin / pharmacology
  • Animals
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology*
  • Digitoxigenin / pharmacology
  • Diltiazem / pharmacology
  • Dogs
  • Monensin / pharmacology
  • Nifedipine / pharmacology
  • Ouabain / pharmacology
  • Sarcolemma / drug effects*
  • Sarcolemma / metabolism
  • Sodium / metabolism*
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Digitoxigenin
  • Alamethicin
  • Ouabain
  • Adenosine Triphosphate
  • Monensin
  • Sodium
  • Verapamil
  • Sodium-Potassium-Exchanging ATPase
  • Diltiazem
  • Nifedipine
  • Calcium